By: Megan Brooks
Patients with BRCA -mutations and a history of early-onset breast cancer benefited from risk-reducing surgeries, according to new data presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
Megan Brooks is a journalist who writes for Medscape and MDEdge. Her articles cover a wide range of medical topics, including new research findings, treatment advancements, and the impact of healthcare policies on patient outcomes. Megan's work provides valuable insights for healthcare professionals and keeps readers informed on the latest developments in the medical field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Megan's coverage spans a broad range of health and scientific topics, with an emphasis on citing data. She is likely to be receptive to pitches from experts who can provide insights supported by credible data or studies within the healthcare and pharmaceutical fields. Given her focus on specific treatments and therapies, she may also be interested in hearing from medical professionals who have experience implementing these treatments or conducting relevant research.
It seems that Megan doesn't have a specified geographic focus, therefore providing information about global trends or developments in the healthcare industry could capture her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .